MUFG Americas’s Utah Medical Products UTMD Stock Holding History

MUFG Americas’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5	Closed	–	–	823
2020 Q4	$0	Buy	+5	New	+$426	﹤0.01%	826

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MUFG Americas's UTMD Position: Q1 2021 in Review

MUFG Americas sold out of Utah Medical Products (UTMD) in Q1 2021, closing a stake of 5 shares.

MUFG Americas first reported a position in UTMD in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 79 funds tracked by Wall St. Rank hold UTMD as of Q1 2021.

MUFG Americas reported no remaining Utah Medical Products position as of Q1 2021 after selling out during the quarter.
MUFG Americas sold 5 Utah Medical Products shares in Q1 2021.
MUFG Americas first reported a position in Utah Medical Products in Q4 2020 and held it in 1 quarter.
MUFG Americas's Utah Medical Products position peaked at $0 in Q4 2020.
79 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2021.

Based on MUFG Americas's 13F filing for Q1 2021, filed 30 Apr 2021.